Jupiter Research Capital (Asia) Ltd’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
LCM
KCM
SL
Jupiter Research Capital (Asia) Ltd's CGEM Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in Cullinan Therapeutics (CGEM) in Q3 2026: 23,474 shares worth $360K. The stake represents 0.04% of the portfolio and ranks #436 among its holdings.
175 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 23,474 shares of Cullinan Therapeutics worth $360K as of Q3 2026.
- Cullinan Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- Cullinan Therapeutics made up 0.04% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #436 holding.
- 175 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.